How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review

Seo, Mikyung Kelly; Cairns, John; (2021) How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review. BMC cancer, 21 (1). p. 980. ISSN 1471-2407 DOI: https://doi.org/10.1186/s12885-021-08725-4

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/s12885-021-08725-4

Abstract

Share

Download

Filename: How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies A systematic review.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar